AD-NP1, Kidney Tissue Repair, Renal Regeneration, Chronic Kidney Disease, CKD, ENPP1, Kidney Injury, Acute Kidney Injury, Nephrology, Regenerative Medicine, Monoclonal Antibody, UCLA Research, Renal Fibrosis, Cell Stem Cell, Kidney Function, Tissue Healing, FDA Phase 1 Trial, Kidney Disease Treatment, Biomedical Research, Healthcare News, Kidney Function Improvement, Acute Kidney Injury, Tissue Regeneration, Nephrology Research, FDA Phase 1 Trial
Kidney Tissue Repair Enhanced by AD-NP1 in Preclinical Study

Key Summary UCLA researchers found that AD-NP1, a monoclonal antibody initially developed for heart tissue.

CAR T-Cell Therapy, Kidney Transplant, Highly Sensitized Patients, End-Stage Kidney Disease, Organ Transplantation, cPRA, Clinical Trial, Immunotherapy, Nephrology, Transplant Surgery, Antibody Reduction, Cell Therapy, Kidney Failure, Transplant Immunology, Penn Medicine, antibody reduction therapy, cellular immunotherapy, transplant surgery, kidney failure treatment, BCMA CAR T cells, CD19 CAR T cells, clinical trial kidney transplantation
CAR T-Cell Therapy Offers Hope for Highly Sensitized Patients

Key Summary Researchers at the University of Pennsylvania successfully used CAR T-cell therapy to reduce.